Pharmacokinetic interaction between methotrexate and chloral hydrate

Pediatr Blood Cancer. 2013 Mar;60(3):518-20. doi: 10.1002/pbc.24393. Epub 2012 Nov 14.

Abstract

We report the case of a drug interaction between methotrexate (MTX) and chloral hydrate (CH) observed in a child treated for acute leukemia. Significantly slower MTX clearance and increased MTX exposure occurred on the first three courses of a high-dose chemotherapy when co-administered with CH despite normal renal function, adequate hydration, and alkalinization. Mean MTX area under the curve associated with CH administration was 1,134 µmol hours/L, compared to 608 µmol hours/L after discontinuation of CH. This interaction possibly resulted from a competition between anionic CH metabolites and MTX for renal tubular excretion.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacokinetics*
  • Child, Preschool
  • Chloral Hydrate / adverse effects*
  • Chloral Hydrate / pharmacokinetics*
  • Drug Interactions
  • Female
  • Humans
  • Hypnotics and Sedatives / adverse effects
  • Hypnotics and Sedatives / pharmacokinetics*
  • Injections, Spinal
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects*
  • Methotrexate / pharmacokinetics*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*

Substances

  • Antineoplastic Agents
  • Hypnotics and Sedatives
  • Chloral Hydrate
  • Methotrexate